Skip to main content
. Author manuscript; available in PMC: 2020 Apr 21.
Published in final edited form as: Biol Psychiatry Cogn Neurosci Neuroimaging. 2019 Feb 4;4(12):1031–1041. doi: 10.1016/j.bpsc.2019.01.009

Table 1.

Participant Demographics and Clinical Characteristics

Variable ASD+DB (n = 18) ASD-only (n = 20) TD (n = 19) p Value
Age, Years, Mean (SD) 12.7 (2.0) 12.6 (2.1) 12.9 (2.2) .895
Male, % 88.9 80.0 73.7 .501
IQa, Mean (SD) 104.4 (15.4) 104.3 (19.1) 112.8 (10.8) .168
Race, % .264
 White 77.8 95.0 68.4
 Black 11.1 0 21.1
 Asian/Pacific Islander 5.6 0 0
 Other> race 5.6 5 10.5
Ethnicity, % .593
 Hispanic 5.6 5 0
 Non-Hispanic 94.4 95 100
CBCL Aggression T Score, Mean (SD) 73.6 (9.1) 50.7 (1.3) 51.2 (3.0) <.001b,c
CBCL Externalizing T Score, Mean (SD) 69.3 (5.8) 44.9 (7.1) 41.1 (7.8) <.001b,c
CBCL Internalizing T Score, Mean (SD) 67.1 (8.6) 54.3 (6.9) 43.1 (6.5) <.001b,d
ICU Total Score, Mean (SD) 31.2 (10.5) 22.5 (10.7) 14.3 (6.7) <.001b,c
ADOS-2 Module 3 Total Score, Mean (SD) 15.7 (3.8) 13.8 (6.1) .263
 Social Affect subscale score, mean (SD) 11.9 (3.2) 10.0 (3.5) .086
 Restricted and Repetitive Behaviors subscale score, mean (SD) 3.78 (1.3) 3.80 (4.2) .983
ADI-R Subscale Scores, Mean (SD)
 Social interaction 19.3 (5.2) 18.6 (4.3) .670
 Communication 15.2 (3.2) 14.8 (4.1) .727
Primary Comorbid Diagnosis (K-SADS), %
 Oppositional defiant disorder 100 0 <.001b
 Attention-deficit/hyperactivity disorder 83.3 35 .003b
 Anxiety disorder 27.8 0 .011b
Currently Taking Medication, % 66.7 20 .004b
Type of Medication, %
 Stimulant 33.3 10
 Antidepressant 27.8 10
 Neuroleptic 22.2 0
 Nonstimulant 22.2 10
 Mood stabilizer 16.7 0
 Benzodiazepine 11.1 0

ASD+DB, autism spectrum disorder with co-occurring disruptive behavior disorder; ASD-only, autism spectrum disorder (without disruptive behavior); ADI-R, Autism Diagnostic Interview–Revised; ADOS-2, Autism Diagnostic Observation Schedule, second edition; CBCL, Child Behavior Checklist; ICU, Inventory of Callous-Unemotional Traits; K-SADS, Schedule for Affective Disorders and Schizophrenia for School-Age Children; TD, typically developing.

a

Full-scale IQ measured by the Wechsler Abbreviated Scale of Intelligence.

b

Significant group differences at p < .05, Bonferroni corrected, except for χ2 test for categorical variables.

c

ASD+DB > ASD-only; ASD+DB > TD.

d

ASD+DB > ASD-only; ASD+DB > TD; ASD-only > TD.